FDA Approved: THAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for THAM (tromethamine) submitted by Hospira, Inc. The action updates the labeling/indication for THAM under NDA013025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Acidosis

Drugs mentioned

• THAM (Tromethamine)

Snippet

SUPPL AP for THAM (TROMETHAMINE)